MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MANNATECH INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)
Close on Oct 19, 2026
- Market cap
- $16.87M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Mannatech's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2026 | Sep 1, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 24, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 22, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2025 | Mar 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2024 | Nov 26, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 27, 2024 | Sep 27, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2024 | Aug 22, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2024 | Jul 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2024 | Apr 29, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 23, 2024 | Apr 23, 2024 | SEC EDGAR |